Capital Change Notice

Capital Change Notice

Updated as at June 2023

Notice of issue of ordinary shares under Oceania’s long term incentive scheme
This notice is given under NZX Listing Rules 3.13.1 and 3.15.2 and relates to the vesting of
performance share rights granted under Oceania’s long term incentive scheme (LTI Scheme)
2021 Grant, pursuant to which selected key executives were issued performance share rights
which entitle them to receive fully paid ordinary shares in Oceania should certain performance
hurdles and vesting criteria be met (Share Rights).
Please see Appendix A for the remaining tranche of Share Rights on issue under the LTI
Scheme.

Section 1: Issuer information
Name of issuer Oceania Healthcare Limited
NZX ticker code OCA
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZOCAE0002SO
Currency NZD
Section 2: Capital change details
Number issued 19,063
Nominal value (if any) N/A
Issue/acquisition/redemption price per security $Nil
Nature of the payment (for example, cash or other
consideration)
N/A
Amount paid up (if not in full) N/A
Percentage of total class of Financial Products issued
(calculated on the number of Financial Products of the
Class, excluding any Treasury Stock, in existence)
1

0.0026%
For an issue of Convertible Financial Products or
Options, the principal terms of Conversion (for example
the Conversion price and Conversion date and the
ranking of the Financial Product in relation to other
Classes of Financial Product) or the Option (for
example, the exercise price and exercise date)
Certain of the Share Rights issued
under the 2021 Grant pursuant to the
LTI Scheme have vested and been
exercised and have converted into
19,063 Ordinary Shares.
Each Share Right entitled the holder
to receive one Ordinary Share in OCA
on vesting and exercise, subject to
adjustment for satisfaction of tax
obligations of the participants. The
exercise price was nil.
The remaining Share Rights under the
LTI Scheme 2021 Grant have lapsed
and been cancelled.
Reason for issue and specific authority for issue (the
reason for change must be identified here)
Issue of ordinary shares under the LTI
Scheme 2021 Grant as a

consequence of the vesting and
exercise of Share Rights previously
granted to retain and incentivise
selected key executives.
Total number of Financial Products of the Class after
the issue (excluding Treasury Stock) and the total
number of Financial Products of the Class held as
Treasury Stock after the issue.
724,231,030 ordinary shares after the
issue.
353,685 total Share Rights on issue.
Details of the tranche of Share Rights
on issue are set out in Appendix A to
this notice.
In the case of an acquisition of shares, whether those
shares are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or
redemption, including a reference to the rule pursuant
to which the issue, acquisition, or redemption is made
Board resolutions dated 25 August
2021 and Listing Rule 4.6.1
Terms or details of the issue, acquisition, or redemption
(for example: restrictions, escrow arrangements)
Terms of the LTI Scheme. The issued
shares rank equally with the other
fully paid ordinary shares on issue.
Date of issue/acquisition/redemption
2
10/07/24
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement Claire Fisher
Contact person for this announcement Claire Fisher
Contact phone number 09 361 0350
Contact email address claire.fisher@oceaniahealthcare.co.nz
Date of release through MAP

11/07/24

Capital Change Notice

Updated as at June 2023
APPENDIX A
SHARE RIGHTS ON ISSUE

Tranche Hurdle Number Commencement
Date
Measurement
Date
Vesting
Date
2022TSR3 TSR
353,685
1 April 2022
31 March
2025
31 March
2025
Total:
353,685